Eli Lilly & Co. (LLY) Misses Q1 EPS by 7c; Guides Raised
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,106.31 +0.70%
EPS Growth %: +39.6%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +39.6%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.62, $0.07 worse than the analyst estimate of $1.69. Revenue for the quarter came in at $6.96 billion versus the consensus estimate of $6.84 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2023 EPS of $8.65-$8.85, versus the consensus of $8.45.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
